Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation
Rebecca G. Watts(Frederick National Laboratory for Cancer Research), Nancy H. Colburn(Gene Therapy Laboratory), Chuanshu Huang(Wenzhou Medical University), Matthew R. Young(NYU Langone Health), William D. Pennie(Pfizer (United States)), Zigang Dong(China-US (Henan) Hormel Cancer Institute), Jian Jian Li(University of California Davis Medical Center)
Cited by 117
Related Papers
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer
|Oncogene|2007|1.9k
An analysis of the attrition of drug candidates from four major pharmaceutical companies
|Nature Reviews Drug Discovery|2015|1.4k
S6K1- and ßTRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell Growth
|Science|2006|712
MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene
|Oncogene|2008|711
The Transformation Suppressor Pdcd4 Is a Novel Eukaryotic Translation Initiation Factor 4A Binding Protein That Inhibits Translation
|Molecular and Cellular Biology|2002|490